SCHEMBL32687977

SCHEMBL32687977

N#Cc1c(-c2ccccc2C(=O)Nc2ccccc2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ HPGD P15428 5/20 0.38
▸ LMNA P02545 3/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CRHBP P24387 1/20 0.37
▸ CRHR2 Q13324 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.37
▸ PKM P14618 1/20 0.37
▸ POLB P06746 3/20 0.36
▸ CHRNB2 P17787 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688192 0.89 ALDH1A1 (0.41) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL32688056 0.87 MET (0.41) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL32688271 0.85 ALDH1A1 (0.42) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL32688221 0.79 SIRT2 (0.46) KMT2AMEN1SMN1; SMN2HTTGAA
SCHEMBL32688138 0.78 KMT2A (0.41) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL32687986 0.78 KMT2A (0.39) KMT2AMEN1ALDH1A1HPGDLMNA
SCHEMBL32688358 0.77 PSMD14 (0.43) ALDH1A1LMNAPOLBMETKDR
SCHEMBL32688127 0.77 MAPT (0.45) KMT2AMEN1ALDH1A1HPGDSMN1; SMN2
SCHEMBL32688247 0.76 ACMSD (0.44) KMT2AALDH1A1HPGD
SCHEMBL32688004 0.76 KMT2A (0.38) KMT2AMEN1CYP3A4CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KMT2A 3400/4885MEN1 4353/4885CYP3A4 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback